Complement inhibitor (By similarity). Prevents complement-mediated C5 activation by binding to C5 (By similarity). Binds C5 at a different binding site than the other tick complement inbibitors OmCI and CirpT1, and the drug eculizumab (By similarity). Expressed by salivary glands. Belongs to the RaCI family.